# Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women

> **NCT00319163** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 26 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** levonorgestrel/ethinyl estradiol

## Key facts

- **NCT ID:** NCT00319163
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 26 (—)
- **Last updated:** 2009-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319163, "Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00319163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*